All Comments by Benjamin Wolozin
- Cholinesterase inhibitors: expanding applications.
- Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway.
- Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts.
- Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion.
- p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
- Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy.
- The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.
- Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
- SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.
- A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
- Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain.
- Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein.
- Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains.
- The effects of nicotine on Parkinson's disease.
- Tau-66: evidence for a novel tau conformation in Alzheimer's disease.